Polθ helicase is crucial for DNA repair and a target for precision medicine for cancer therapy. Here, the authors reveal the mechanism of action of the small-molecule inhibitor AB25583, and show its high specificity and selective killing of BRCA1/2– cancer cells and synergy with olaparib.
- Fumiaki Ito
- Ziyuan Li
- Richard T. Pomerantz
